METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS

• 收藏
• 分享

专利权人:

INC.;NEUROCRINE BIOSCIENCES

发明人:

O'BRIEN, Christopher,BOZIGIAN, Haig

申请号：

SG11201906883S

公开号：

SG11201906883SA

申请日:

2017.10.10

申请国别(地区):

SG

年份:

2019

代理人:

摘要：

WO 18/ 14009 4 Al (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 02 August 2018 (02.08.2018) WIP0 I PCT mu °million °nolo olomonlioimommo oimIE (10) International Publication Number WO 2018/140094 Al (51) International Patent Classification: A61K 31/473 (2006.01) C07D 455/06 (2006.01) C07D 455/04 (2006.01) (21) International Application Number: PCT/US2017/055931 (22) International Filing Date: 10 October 2017 (10.10.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/451,605 27 January 2017 (27.01.2017) US (72) Inventor； and (71) Applicant: O'BRIEN, Christopher F. [US/US]； 12780 El Camino Real, San Diego, CA 92130 (US). (74) Agent: STEVENS, Lauren L.； Dennemeyer & Associates, LLC, 2 N. Riverside Plaza, Suite 1500, Chicago, IL 60606 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/